NO180232C - Karboksylsyrederivater, legemidler inneholdende disse, og anvendelse av disse for fremstilling av legemidler - Google Patents
Karboksylsyrederivater, legemidler inneholdende disse, og anvendelse av disse for fremstilling av legemidlerInfo
- Publication number
- NO180232C NO180232C NO933647A NO933647A NO180232C NO 180232 C NO180232 C NO 180232C NO 933647 A NO933647 A NO 933647A NO 933647 A NO933647 A NO 933647A NO 180232 C NO180232 C NO 180232C
- Authority
- NO
- Norway
- Prior art keywords
- medicaments
- manufacture
- carboxylic acid
- acid derivatives
- medicaments containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4234295A DE4234295A1 (de) | 1992-10-12 | 1992-10-12 | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
Publications (4)
Publication Number | Publication Date |
---|---|
NO933647D0 NO933647D0 (no) | 1993-10-11 |
NO933647L NO933647L (no) | 1994-04-13 |
NO180232B NO180232B (no) | 1996-12-02 |
NO180232C true NO180232C (no) | 1997-03-12 |
Family
ID=6470224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO933647A NO180232C (no) | 1992-10-12 | 1993-10-11 | Karboksylsyrederivater, legemidler inneholdende disse, og anvendelse av disse for fremstilling av legemidler |
Country Status (19)
Country | Link |
---|---|
US (1) | US5442064A (no) |
EP (1) | EP0592949A3 (no) |
JP (1) | JPH06199788A (no) |
KR (1) | KR940009164A (no) |
CN (1) | CN1087904A (no) |
AU (1) | AU668765B2 (no) |
CA (1) | CA2108093A1 (no) |
CZ (1) | CZ212893A3 (no) |
DE (1) | DE4234295A1 (no) |
FI (1) | FI934460A (no) |
HU (1) | HU9302875D0 (no) |
IL (1) | IL107221A0 (no) |
MX (1) | MX9306303A (no) |
NO (1) | NO180232C (no) |
NZ (1) | NZ248894A (no) |
PL (1) | PL300673A1 (no) |
SK (1) | SK107293A3 (no) |
TW (1) | TW293815B (no) |
ZA (1) | ZA937502B (no) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL116893A (en) * | 1995-02-10 | 2000-02-29 | Yamanouchi Pharma Co Ltd | Piperazine derivatives and pharmaceutical compositions containing them |
DE19516483A1 (de) | 1995-05-05 | 1996-11-07 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
WO1997002245A1 (fr) * | 1995-07-06 | 1997-01-23 | Japan Tobacco Inc. | Derives de benzamidoxime et leur utilisation a des fins medicinales |
DE19652919A1 (de) * | 1996-12-19 | 1998-06-25 | Solvay Pharm Gmbh | Piperazinophenyl- und Piperazinophenyloxy-carbonsäure-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
US6630137B1 (en) * | 1997-04-28 | 2003-10-07 | Eli Lilly And Company | Activated protein C formulations |
KR100564189B1 (ko) | 1997-04-28 | 2006-03-27 | 일라이 릴리 앤드 캄파니 | 활성화 프로틴c의 가공을 위한 개선된 방법 |
DE19743435A1 (de) * | 1997-10-01 | 1999-04-08 | Merck Patent Gmbh | Benzamidinderivate |
FR2781220B1 (fr) * | 1998-07-17 | 2000-10-13 | Lafon Labor | Piperazinones substituees en beta |
CN1129581C (zh) | 1998-09-22 | 2003-12-03 | 山之内制药株式会社 | 氰基苯基衍生物 |
AU1465301A (en) * | 1999-11-08 | 2001-06-06 | Schering Corporation | Process for preparing n-(4-hydroxy-phenyl)-n'-(4'-aminophenyl)-piperazine |
US7204981B2 (en) * | 2000-03-28 | 2007-04-17 | Eli Lilly And Company | Methods of treating diseases with activated protein C |
US20020045613A1 (en) * | 2000-04-27 | 2002-04-18 | Heinz Pauls | 1-aroyl-piperidinyl benzamidines |
GB0012362D0 (en) * | 2000-05-22 | 2000-07-12 | Aventis Pharma Ltd | Chemical compounds |
WO2001089558A2 (en) | 2000-05-24 | 2001-11-29 | Eli Lilly And Company | Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states |
NZ523526A (en) | 2000-07-20 | 2004-10-29 | Neurogen Corp | Diaryl piperazines as capsaicin receptor ligands |
ES2345044T3 (es) * | 2002-02-01 | 2010-09-14 | Euro-Celtique S.A. | 2-piperazin-piridinas utiles para tratar el dolor. |
DE60325025D1 (de) | 2002-02-15 | 2009-01-15 | Glaxo Group Ltd | Modulatoren des vanilloidrezeptors |
JP2005528351A (ja) * | 2002-03-08 | 2005-09-22 | イーライ・リリー・アンド・カンパニー | 活性化プロテインc製剤 |
RS114804A (en) * | 2002-06-28 | 2006-12-15 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
US7262194B2 (en) * | 2002-07-26 | 2007-08-28 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
US7157462B2 (en) * | 2002-09-24 | 2007-01-02 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
CA2526361C (en) | 2003-05-20 | 2012-05-15 | Ajinomoto Co., Inc. | Amide derivative |
MY142655A (en) * | 2003-06-12 | 2010-12-15 | Euro Celtique Sa | Therapeutic agents useful for treating pain |
DK1867644T3 (da) | 2003-07-24 | 2009-09-21 | Euro Celtique Sa | Heteroaryl-tetrahydropyridyl-forbindelser, der er anvendelige til behandling eller forebyggelse af smerte |
WO2005030753A2 (en) * | 2003-09-22 | 2005-04-07 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
PL1664041T3 (pl) * | 2003-09-22 | 2008-12-31 | Euro Celtique Sa | Przydatne do leczenia bólu związki fenylowo-karboksyamidowe |
TWI350168B (en) * | 2004-05-07 | 2011-10-11 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
AU2005267331A1 (en) * | 2004-06-24 | 2006-02-02 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
CA2584502A1 (en) * | 2004-06-24 | 2006-01-05 | Incyte Corporation | 2-methylpropanamides and their use as pharmaceuticals |
EP1773773A4 (en) * | 2004-06-24 | 2009-07-29 | Incyte Corp | AMID COMPOUNDS AND THEIR USE AS MEDICAMENTS |
NZ551603A (en) | 2004-06-24 | 2010-11-26 | Incyte Corp | N-substituted piperidines and their use as pharmaceuticals |
US20060122197A1 (en) * | 2004-08-10 | 2006-06-08 | Wenqing Yao | Amido compounds and their use as pharmaceuticals |
WO2006053024A2 (en) * | 2004-11-10 | 2006-05-18 | Incyte Corporation | Lactam compounds and their use as pharmaceuticals |
US8110581B2 (en) * | 2004-11-10 | 2012-02-07 | Incyte Corporation | Lactam compounds and their use as pharmaceuticals |
BRPI0518281A2 (pt) * | 2004-11-18 | 2008-11-18 | Incyte Corp | inibidores de 11-beta hidroxilesteràide desidrogenase do tipo i e mÉtodos uso dos mesmos |
NZ555770A (en) | 2004-12-24 | 2010-12-24 | Astrazeneca Ab | Heterocyclic piperazine-carboxamide compounds as CCR2B antagonists |
CA2621255A1 (en) * | 2005-09-21 | 2007-04-05 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
TW200804382A (en) * | 2005-12-05 | 2008-01-16 | Incyte Corp | Lactam compounds and methods of using the same |
GB0525957D0 (en) | 2005-12-21 | 2006-02-01 | Astrazeneca Ab | Methods |
WO2007084314A2 (en) * | 2006-01-12 | 2007-07-26 | Incyte Corporation | MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
JP2009525333A (ja) * | 2006-01-31 | 2009-07-09 | インサイト・コーポレイション | アミド化合物およびその医薬としての使用 |
TW200808807A (en) * | 2006-03-02 | 2008-02-16 | Incyte Corp | Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
WO2007103719A2 (en) * | 2006-03-03 | 2007-09-13 | Incyte Corporation | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
US20070293529A1 (en) * | 2006-05-01 | 2007-12-20 | Yun-Long Li | Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1 |
US7838544B2 (en) * | 2006-05-17 | 2010-11-23 | Incyte Corporation | Heterocyclic inhibitors of 11-β hydroxyl steroid dehydrogenase type 1 and methods of using the same |
ES2293834B1 (es) * | 2006-07-20 | 2009-02-16 | Consejo Superior Investig. Cientificas | Compuesto con actividad inhibidora de las interacciones ubc13-uev, composiciones farmaceuticas que lo comprenden y sus aplicaciones terapeuticas. |
MY148657A (en) * | 2007-04-27 | 2013-05-15 | Purdue Pharma Lp | Trpv1 antagonists and uses thereof |
AU2011226773C1 (en) * | 2007-04-27 | 2012-07-26 | Purdue Pharma L.P. | TRPV1 antagonists and uses thereof |
RU2452733C2 (ru) * | 2007-04-27 | 2012-06-10 | Пэдью Фарма Л.П. | Антагонисты trpv1 и их применение |
NZ579820A (en) * | 2007-04-27 | 2011-01-28 | Purdue Pharma Lp | Therapeutic agents useful for treating pain |
ATE528310T1 (de) * | 2007-05-04 | 2011-10-15 | Astrazeneca Ab | Verfahren zur synthese von alkylphosphinsäuren durch initiierung eines amins und eines aminoxids |
CL2008001839A1 (es) * | 2007-06-21 | 2009-01-16 | Incyte Holdings Corp | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. |
US7946206B2 (en) * | 2007-11-21 | 2011-05-24 | Rocksmart, Llc | Quick-release system |
KR20110098779A (ko) | 2008-12-03 | 2011-09-01 | 프레시디오 파마슈티칼스, 인코포레이티드 | Hcv ns5a의 억제제 |
US20100152197A1 (en) * | 2008-12-15 | 2010-06-17 | Astrazeneca Ab | (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives |
AU2010204723A1 (en) * | 2009-01-14 | 2011-08-18 | The Salk Institute For Biological Studies | Methods for screening and compounds that protect against amyloid diseases |
ME02609B (me) | 2011-06-22 | 2017-06-20 | Purdue Pharma Lp | TRPV1 ANTAGONISTI KOJI UKLJUČUJU DIHIDROKSI SUPSTITUENT l NJIHOVE UPOTREBE |
WO2013146969A1 (ja) * | 2012-03-29 | 2013-10-03 | 第一三共株式会社 | 新規二置換シクロヘキサン誘導体 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256812A (en) * | 1989-01-31 | 1993-10-26 | Hoffmann-La Roche Inc. | Carboxamides and sulfonamides |
US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
DE4102024A1 (de) * | 1991-01-24 | 1992-07-30 | Thomae Gmbh Dr K | Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE69203797T2 (de) * | 1991-06-11 | 1996-02-08 | Ciba Geigy Ag | Amidino-Verbindungen, ihre Herstellung und Verwendung als Arzneimittel. |
DE4127404A1 (de) * | 1991-08-19 | 1993-02-25 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
GB9122016D0 (en) * | 1991-10-16 | 1991-11-27 | Glaxo Group Ltd | Chemical compounds |
GB9208740D0 (en) * | 1992-04-23 | 1992-06-10 | Glaxo Group Ltd | Chemical compounds |
DE4303840A1 (de) * | 1992-10-22 | 1994-08-11 | Thomae Gmbh Dr K | Aryliden-1-azacycloalkane und Arylalkyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung |
WO1994012181A1 (en) * | 1992-12-01 | 1994-06-09 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
-
1992
- 1992-10-12 DE DE4234295A patent/DE4234295A1/de not_active Withdrawn
-
1993
- 1993-09-10 TW TW082107457A patent/TW293815B/zh active
- 1993-10-05 SK SK1072-93A patent/SK107293A3/sk unknown
- 1993-10-07 EP EP19930116244 patent/EP0592949A3/de not_active Withdrawn
- 1993-10-08 CA CA002108093A patent/CA2108093A1/en not_active Abandoned
- 1993-10-08 JP JP5252019A patent/JPH06199788A/ja active Pending
- 1993-10-08 NZ NZ248894A patent/NZ248894A/en unknown
- 1993-10-11 KR KR1019930021147A patent/KR940009164A/ko not_active Application Discontinuation
- 1993-10-11 IL IL107221A patent/IL107221A0/xx unknown
- 1993-10-11 ZA ZA937502A patent/ZA937502B/xx unknown
- 1993-10-11 MX MX9306303A patent/MX9306303A/es unknown
- 1993-10-11 PL PL93300673A patent/PL300673A1/xx unknown
- 1993-10-11 NO NO933647A patent/NO180232C/no unknown
- 1993-10-11 FI FI934460A patent/FI934460A/fi not_active Application Discontinuation
- 1993-10-11 AU AU48939/93A patent/AU668765B2/en not_active Ceased
- 1993-10-11 CZ CZ932128A patent/CZ212893A3/cs unknown
- 1993-10-11 HU HU9302875A patent/HU9302875D0/hu unknown
- 1993-10-12 CN CN93118925A patent/CN1087904A/zh active Pending
- 1993-10-12 US US08/135,041 patent/US5442064A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0592949A2 (de) | 1994-04-20 |
NO933647L (no) | 1994-04-13 |
SK107293A3 (en) | 1994-08-10 |
NO180232B (no) | 1996-12-02 |
HU9302875D0 (en) | 1993-12-28 |
PL300673A1 (en) | 1994-05-16 |
AU668765B2 (en) | 1996-05-16 |
US5442064A (en) | 1995-08-15 |
DE4234295A1 (de) | 1994-04-14 |
NO933647D0 (no) | 1993-10-11 |
TW293815B (no) | 1996-12-21 |
NZ248894A (en) | 1996-01-26 |
FI934460A0 (fi) | 1993-10-11 |
KR940009164A (ko) | 1994-05-20 |
CZ212893A3 (en) | 1994-04-13 |
CA2108093A1 (en) | 1994-04-13 |
CN1087904A (zh) | 1994-06-15 |
EP0592949A3 (en) | 1994-08-10 |
ZA937502B (en) | 1995-04-11 |
MX9306303A (es) | 1994-04-29 |
AU4893993A (en) | 1994-04-28 |
IL107221A0 (en) | 1994-01-25 |
FI934460A (fi) | 1994-04-13 |
JPH06199788A (ja) | 1994-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO180232C (no) | Karboksylsyrederivater, legemidler inneholdende disse, og anvendelse av disse for fremstilling av legemidler | |
NO942720L (no) | 1,5-benzobiazepinderivater og medisinsk anvendelse av disse | |
NO301420B1 (no) | Chinolon- og naftyridon-karboksylsyrederivater og anvendelse av disse | |
AU1388388A (en) | Benzoic acid derivatives and use thereof | |
NO922291D0 (no) | 7-azaisoindolinyl-kinolon- og naftyridonkarboksylsyrederivater | |
EE9700153A (et) | Heterotsükliga kondenseerunud püridiinid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
NO304774B1 (no) | Tetrahydrokarbazolderivater, farmas÷ytiske blandinger inneholdende slike og anvendelse av disse derivater | |
DK318288A (da) | Konditioneringsmiddel og produkter indeholdende samme | |
NO304488B1 (no) | 5-leddede heteroaryloksazolidinoner, anvendelse av disse for fremstilling av legemidler samt legemiddel inneholdende forbindelsen | |
NO934501D0 (no) | Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmaat e for deres fremstilling | |
DK157931C (da) | 1,3-dihydro-6-methyl-7-hydroxy-furo-(3,4-c)-pyridinderivater og terapeutisk acceptable syreadditionssalte deraf samt farmaceutiske praeparater indeholdende disse | |
NO922226D0 (no) | 7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater | |
DK431586A (da) | Benzimidazolderivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende disse | |
IL101771A0 (en) | Carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them | |
IS3951A (is) | Cephalosporinafleiður, aðferð til framleiðslu þeirra og notkunar sem lyfja | |
IL103058A0 (en) | Bicyclic carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them | |
NO891122D0 (no) | Platinakoordinasjonsforbindelser og anvendelse av forbindelsene i kjemoterapi. | |
EP0429304A3 (en) | Pyridone-carboxylic acid derivatives and their use as veterinary medicines | |
EE9600023A (et) | Fenüültsükloheksüülkarboksüülhappeamiidid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud ühendeid sisaldavad ravimid ja nende valmistamismeetod | |
HU9203867D0 (en) | Method for producing benzoic acid derivatives and pharmaceutical preparatives containing them | |
EP0519763A3 (en) | Cyclohexylbutyric acid derivatives and their use in the production of optically active cyclohexylnorstatine | |
NO307080B1 (no) | Fremgangsmåte for fremstilling av katalysatorer og anvendelse derav | |
IL102099A0 (en) | Propenoic acid derivatives and their use as fungicides | |
NO923455D0 (no) | Indolsulfonamidsubstituert dihydropyridin, fremgangsmaate for fremstilling og anvendelse i legemidler | |
NO864717D0 (no) | Carboxylgruppeholdige polyamider og fremgangsmaate for fremstilling av disse. |